Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02380690
Other study ID # IIR 14-070
Secondary ID 1410626162
Status Completed
Phase N/A
First received
Last updated
Start date May 1, 2015
Est. completion date August 1, 2019

Study information

Verified date July 2023
Source VA Office of Research and Development
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To maximize implementation potential of pain self-management in the VA, alternative delivery methods are needed to provide Veterans with education and support needed to self-manage their pain, without requiring additional resources from healthcare teams. A novel and promising approach is a peer coaching model, in which Veterans with chronic pain who are successfully managing their pain offer information, support, and mentorship to other Veterans with pain.


Description:

The investigators' goal is to test the effectiveness of a peer coaching model among Veterans. The investigators are examining feasibility for implementation alongside effectiveness, to shorten the timeline to implementation. Aim 1 (primary aim): To compare 6-month (primary endpoint) and 9-month (sustained effects) effects of peer-supported chronic pain self-management versus controls on overall pain (intensity and function). Hypothesis 1: Veterans in the peer support arm will experience reduced overall pain compared to controls. Aim 2 (secondary aim): To compare 6- and 9-month effects of peer-supported chronic pain self-management versus controls on self-efficacy, social support, pain coping, patient activation, health-related quality of life, and health service utilization. Hypothesis 2: Veterans in the peer support arm will experience greater self-efficacy, social support, pain coping, patient activation, and health-related quality of life, and lower health service utilization, compared to controls. Aim 3 (pre-implementation aim): To explore facilitators and barriers to implementation of peer support for chronic pain, intervention costs, and fidelity to the model.


Recruitment information / eligibility

Status Completed
Enrollment 215
Est. completion date August 1, 2019
Est. primary completion date August 1, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - have musculoskeletal pain in the low back, cervical spine, or extremities (hip, knee, or shoulder) for 3 months - have at least moderate pain severity, defined by pain 5 on a 0 (no pain) to 10 (worst pain imaginable) scale - indicate willingness to engage in phone or in-person contact on a regular basis with another Veteran Exclusion Criteria: - if the electronic medical record indicates a diagnosis of a psychotic disorder (e.g., International Classification of Diseases (ICD) ICD-9 codes 295-295.9 for schizophrenia) - current substance dependence (e.g., ICD-9 codes 304-304.9) - severe medical conditions precluding participation (e.g., New York Heart Association Class III or IV heart failure, ICD-9 codes 428-428.9 ) - if the eligibility screener given to prospective participants reveals active suicidal ideation severe hearing or speech impairment - pending surgery for a musculoskeletal condition (e.g., back surgery)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Peer Coach Assignment
Veterans will be assigned a peer coach to meet with for 6 months to discuss pain self-management.

Locations

Country Name City State
United States Richard L. Roudebush VA Medical Center, Indianapolis, IN Indianapolis Indiana

Sponsors (1)

Lead Sponsor Collaborator
VA Office of Research and Development

Country where clinical trial is conducted

United States, 

References & Publications (4)

Matthias MS, Bair MJ, Ofner S, Heisler M, Kukla M, McGuire AB, Adams J, Kempf C, Pierce E, Menen T, McCalley S, Johnson NL, Daggy J. Peer Support for Self-Management of Chronic Pain: the Evaluation of a Peer Coach-Led Intervention to Improve Pain Symptoms — View Citation

Matthias MS, Daggy J, Adams J, Menen T, McCalley S, Kukla M, McGuire AB, Ofner S, Pierce E, Kempf C, Heisler M, Bair MJ. Evaluation of a peer coach-led intervention to improve pain symptoms (ECLIPSE): Rationale, study design, methods, and sample character — View Citation

Matthias MS, Daggy J, Ofner S, McGuire AB, Kukla M, Bair MJ. Exploring peer coaches' outcomes: Findings from a clinical trial of patients with chronic pain. Patient Educ Couns. 2020 Jul;103(7):1366-1372. doi: 10.1016/j.pec.2020.02.007. Epub 2020 Feb 5. — View Citation

Shue SA, McGuire AB, Matthias MS. Facilitators and Barriers to Implementation of a Peer Support Intervention for Patients with Chronic Pain: A Qualitative Study. Pain Med. 2019 Jul 1;20(7):1311-1320. doi: 10.1093/pm/pny229. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Brief Pain Inventory (BPI) (Overall Pain Assessment) The BPI was developed to assess the severity of pain and the impact of pain on daily functioning, and has been validated in primary care studies. (Range = 0-10, 0 = no pain, 10 = worst pain imaginable) 6 months
Primary Brief Pain Inventory (BPI) (Overall Pain Assessment) The BPI was developed to assess the severity of pain and the impact of pain on daily functioning, and has been validated in primary care studies. (Range = 0-10, 0 = no pain, 10 = worst pain imaginable) 9 months
Secondary Pain Catastrophizing Pain Catastrophizing Scale, a 13-item scale that assesses catastrophizing - a pain belief that has been found to be a strong predictor of poor treatment response. (Range: 0-52, higher numbers = higher catastrophizing) 6 months
Secondary Perceived Social Support Measures perceptions of social support.(Range: 12-84, higher numbers = higher perceptions of social support) 6 months
Secondary Perceived Social Support Measures perceptions of social support.(Range: 12-84, higher numbers = higher perceptions of social support) 9 months
Secondary Self Efficacy Adapted from the Arthritis Self Efficacy Scale (Range 0-10, higher numbers = higher self efficacy) 6 months
Secondary Self Efficacy Adapted from the Arthritis Self Efficacy Scale (Range 0-10, higher numbers = higher self efficacy) 9 months
Secondary Anxiety GAD-7 (Range 0-21, higher numbers = higher anxiety) 6 months
Secondary Anxiety GAD-7 (Range 0-21, higher numbers = higher anxiety) 9 months
Secondary Depression PHQ-8 (Range: 0-24, higher numbers = higher depression) 6 months
Secondary Depression PHQ-8 (Range: 0-24, higher numbers = higher depression) 9 months
Secondary Pain Catastrophizing Pain Catastrophizing Scale, a 13-item scale that assesses catastrophizing - a pain belief that has been found to be a strong predictor of poor treatment response. (Range: 0-52, higher numbers = higher catastrophizing) 9 months
Secondary Patient Activation Patient Activation Measure (Range: 0-100, higher numbers = higher activation) 6 months
Secondary Patient Activation Patient Activation Measure (Range: 0-100, higher numbers = higher activation) 9 months
Secondary General Health Perceptions SF-36 General Health Perceptions (Range: 0-100, higher numbers = higher health perceptions) 6 months
Secondary General Health Perceptions SF-36 General Health Perceptions (Range: 0-100, higher numbers = higher health perceptions) 9 months
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain